Press Releases

Page Category: 

BOTHELL, WA, February 26, 2002 - Sonosite, Inc. (Nasdaq: SONO), world leaders in the hand-carried, point-of-care ultrasound market, today announced a renewable agreement to provide the Sonosite 180PLUS and the SonoHeart ELITE hand-carried ultrasound systems to both hospital facilities and deployable operations within the federal government healthcare system. This agreement makes Sonosite a provider of hand-carried ultrasound for federal agencies and the military in the United States and became effective February 12, 2002.

"Over the past two years, the Company has made significant progress by shipping over 90 Sonosite systems to federal agencies and the military, both domestically and abroad," said Ronald S. Dickson, vice president of U.S. sales. "Our agreement will streamline the acquisition process for U.S. federal agencies and the military, allowing them to purchase our hand-carried ultrasound systems more expeditiously and with greater ease through the Defense Supply Center in Philadelphia, Pennsylvania."

BOTHELL, WA, February 22, 2002 - Sonosite, Inc. (Nasdaq: SONO), today announced the filing with the Securities and Exchange Commission, or SEC, of a registration statement for a proposed public offering of 2,700,000 shares of its common stock. All of the shares will be offered by Sonosite. UBS Warburg LLC and Deutsche Banc Alex. Brown will serve as managing underwriters for the offering. Sonosite has granted the underwriters an option to purchase up to an additional 405,000 shares to cover any over-allotments. Copies of the preliminary prospectus relating to this offering are not yet available.

When available, they may be obtained from UBS Warburg LLC, Prospectus Department, 299 Park Avenue, New York, New York 10171, telephone: (212) 821-3000. Sonosite, Inc. (, headquartered in Bothell, WA, is a leading provider of high performance, highly miniaturized, hand-carried, all-digital ultrasound devices for use in a variety of clinical applications and settings. A registration statement relating to these securities has been filed with the SEC but has not yet become effective.

Sonosite Hand-carried Ultrasound Systems Integral Part of Medical Support at the Winter Games BOTHELL, WA, February 19, 2002 - Sonosite, Inc. (Nasdaq: SONO), world leaders in the hand-carried, point-of-care ultrasound market, today announced that the Company has delivered two Sonosite 180PLUS hand-carried ultrasound systems for use by the medical organization that has accompanied the German Olympic team to Salt Lake City.

"My colleagues and I view this hand-carried ultrasound system to be an ideal medical tool at the Olympic games," said Georg Huber, MD, Department of Preventative and Rehabilitative Sports Medicine at the University Hospital of Freiburg, Germany, and head of the German Olympic teams" medical support staff. "The image quality is excellent for the applications we have in mind and the portability is essential. A major advantage of the Sonosite system is that it is available for use the very moment we need it and can be used...

BOTHELL, WA, February 18, 2002 - Sonosite, Inc. (Nasdaq: SONO) today announces the promotion of Blake Little to vice president of engineering. In his new role, Little will oversee engineering operations for the Company. Prior to his promotion, he was director of engineering for Sonosite. "Blake has proven to be an integral part of Sonosite's management team and is a key player of Sonosite's successful engineering team that continually delivers high-quality innovation on schedule," said Jens U. Quistgaard, Chief Product and Marketing Officer of Sonosite.

"As our products continue to gain widespread acceptance in the medical community, we are discovering more and more opportunities to bring truly portable ultrasound technology to both traditional and new users of ultrasound. Blake's promotion to vice president of engineering marks another step in our continual evolution as the leaders in the hand-carried ultrasound market."

Company Achieves $15.3 Million in Quarterly Revenues with Gross Margins of 57.6%. Full Year Revenues Come in at $45.7 Million. Sonosite Launches SonoHeart ELITE System for Cardiology and Opens Direct Operation in Spain BOTHELL, WA, February 14, 2002 - Sonosite, Inc. (Nasdaq: SONO) today released financial results for the fourth quarter and year ended December 31, 2001. For the quarter Sonosite reported product revenues of $15.3 million, up 29 percent sequentially and 129 percent over Q4 2000. Gross margins increased for the fourth consecutive quarter to 57.6 percent, an improvement of 22.9 percentage points over Q4 2000. For the year, the Company achieved $45.7 million in revenues, up 43 percent over the prior year, and gross margins of 52.2 percent, up 10.4 percentage points over the prior year.

Sonosite reported a quarterly net loss of $2.4 million, or $0.21 per share, compared to a net loss of $8.2 million,...

The SonoHeart ELITE Hand-carried Ultrasound System Debuts with Accolades from Cardiologists and Sonographers Nationwide

Complete Echocardiography Capabilities in a Full-Featured Hand-Carried Ultrasound System, Weighing Less than Six Pounds

BOTHELL, WA, February 4, 2002 - Sonosite, Inc. (Nasdaq: SONO) today introduces the SonoHeart ELITE system, the first all-digital, hand-carried ultrasound system with continuous wave (CW) Doppler and Extended Resolution Harmonic (ERH) Imaging. The new capabilities allow for quantification of blood flow in the heart with CW Doppler and enhanced two-dimensional image quality with ERH.

This new system, developed in response to market feedback, now allows trained clinicians to perform complete cardiac ultrasound exams in any number of clinical settings. Sonosite previewed the SonoHeart ELITE system to various physicians and sonographers throughout the United States. As a result, the Company has received several order commitments from clinicians involved in the preference evaluations.

The system will be showcased...

BOTHELL, WA, July 30, 2002 - Sonosite, Inc. (Nasdaq: SONO) today announced that, effective August 5, Jens U. Quistgaard, Ph.D., Sonosite's chief product and strategy officer, will leave the Company to become the president and chief executive officer of LipoSonix, Inc., a private company based in the Seattle area.

LipoSonix is developing medical devices for cosmetic surgery applications and is not a Sonosite competitor. "Jens has been with Sonosite since the beginning when we were the Handheld Systems Business Group at ATL Ultrasound five years ago," said Kevin M. Goodwin, Sonosite's president and CEO.

"Under his leadership, our product development and marketing groups have delivered ground-breaking products and strong market progress. Jens deserves an opportunity like this, and we wish him the best. "Blake Little, vice president of engineering, will become the Company's senior engineering officer and technology spokesperson," Goodwin continued. "Blake has been instrumental in the development and release of all of Sonosite's products, including our newest product line that we will be launching in the next several weeks.

Conference Call Accessible Via Live Webcast BOTHELL, WA, January 30, 2002 - Sonosite, Inc. (Nasdaq: SONO), today announced that the Company will report its fourth quarter and 2001 year-end earnings results on Thursday, February 14, 2002, after market close. Sonosite's management team will host a conference call on Thursday, February 14 at 1:30 p.m. (PT) to discuss the Company's fourth quarter and year-end results.

The call will be broadcast live via the "Investors" section of Sonosite's corporate website: A replay of the call will be available by calling (719) 457- 0820 or toll-free (888) 203-1112. Replay access will be available until 4:30 p.m. (PT) on February 15, 2002. The access code 760502 is required for replay access. The call will be archived on Sonosite's website until March 14, 2002, at

About Sonosite

BOTHELL, WA, January 28, 2002 - Sonosite, Inc. (Nasdaq: SONO), world leaders in the hand-carried, point-of-care ultrasound market, today announced a two-year agreement with the leading medical equipment supplier in the United Kingdom, National Health Service (NHS), to provide NHS customers the Sonosite 180PLUS and the SonoHeart PLUS systems. NHS is responsible for purchase and supply management of over 85 percent of all medical equipment sales in the U.K. The agreement became effective January 1, 2002.

"We are very pleased to award Sonosite our national contract, which allows supplies managers in all NHS Trust Hospitals to purchase Sonosite systems without the complexities involved with the tender process normally associated with ultrasound system purchases," said Sue Hartell, Radiology Buyer, Diagnostic Medical Equipment, NHS Purchasing and Supply Agency, U.K. "

We are honored the NHS has selected Sonosite to participate in this national contract, which indicates the widespread acceptance Sonosite systems are gaining in the U.K. - the fourth largest ultrasound market in Europe," Kevin M. Goodwin, president and CEO of Sonosite, Inc. "Our agreement is a major milestone for the Company's future growth in the U.K. and marks the beginning of a strong partnership with NHS."

About National Health Service (NHS)

RECORD QUARTERLY REVENUES OF $89 Million, UP 27% VERSUS FOURTH QUARTER 2009 US Sector Achieves an All Time High in Quarterly Revenues of $40 Million, Up 35% VisualSonics (VSI) Acquisition Delivers Second Consecutive Strong Quarter Company Experienced Improving Momentum and Market Dynamics BOTHELL, WA - January 10, 2011 - Sonosite, Inc. (Nasdaq: SONO), the world leader and specialist in bedside and point-of-care ultrasound, today announced preliminary revenue results for the fourth quarter and year ended December 31, 2010. Revenue for the fourth quarter was approximately $89 million, an increase of 27% for the quarter.

Full-year 2010 revenue reached $275 million compared to $227 million in 2009, an increase of 21%. VisualSonics revenue was $8.8 million for the quarter, representing the second consecutive strong performance since the company was acquired in June 2010. Sonosite revenue, excluding VSI, was approximately $80 million, an increase of 15% compared to the fourth quarter of 2009, and $257 million for the full-year, an increase of 13%.